Zacks Company Profile for ThermoGenesis Holdings, Inc. (THMO : NSDQ) |
|
|
|
Company Description |
ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California.
Number of Employees: 41 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $1.26 |
Daily Weekly Monthly
 |
20 Day Moving Average: 169,658 shares |
Shares Outstanding: 1.90 (millions) |
Market Capitalization: $2.40 (millions) |
Beta: 2.59 |
52 Week High: $19.80 |
52 Week Low: $1.20 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-35.38% |
-37.83% |
12 Week |
-48.78% |
-52.45% |
Year To Date |
-60.63% |
-64.18% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Chris Xu - Chief Executive Officer and Chairman
Haihong Zhu - Chief Operating Officer
Jeff Cauble - Chief Financial Officer
Vivian Liu - Director
Russell Medford - Director
|
|
Peer Information
ThermoGenesis Holdings, Inc. (CORR.)
ThermoGenesis Holdings, Inc. (RSPI)
ThermoGenesis Holdings, Inc. (CGXP)
ThermoGenesis Holdings, Inc. (BGEN)
ThermoGenesis Holdings, Inc. (GTBP)
ThermoGenesis Holdings, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 88362L209
SIC: 3821
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/23
Next Expected EPS Date: 08/10/23
|
|
Share - Related Items
Shares Outstanding: 1.90
Most Recent Split Date: 12.00 (0.02:1)
Beta: 2.59
Market Capitalization: $2.40 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.01 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-1.92 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/10/23 |
|
|
|
|